Vivir Con Parkinson
Vivir Con Parkinson
Vivir Con Parkinson
NAME OF AUTHORS
Leire AMBROSIO, RN, MSc, PhD. Faculty of Nursing, University of Navarre. Pamplona,
Navarre, Spain. lambrosio@unav.es
Mari Carmen PORTILLO, RN, MSc, PhD. Faculty of Health Sciences. University of
Southampton. Southampton, UK. M.C.Portillo-Vega@soton.ac.uk
Jose Manuel ROJO, PhD. Department of Statistics, Center of Human and Social
Sciences, Spanish Council for Scientific Research. Madrid, Spain.
josemanuel.rojo@cchs.csic.es
EC-PC Validation Group: Mayela Rodriguez Violante, Juan Carlos Martinez Castrillo,
Victor Campos Arillo, Nelida Susana Garretto, Tomoko Arakaki, Marcos Serrano Dueñas,
Mario Alvarez.
This article has been accepted for publication and undergone full peer review but has not
been through the copyediting, typesetting, pagination and proofreading process, which
may lead to differences between this version and the Version of Record. Please cite this
article as doi: 10.1111/jocn.14868
This article is protected by copyright. All rights reserved.
CORRESPONDING AUTHOR. Mari Carmen PORTILLO. Building 67. Highfield
Campus University Road S0171BJ. Southampton, Hampshire, United Kingdom. E-mail:
M.C.Portillo-Vega@soton.ac.uk. Phone number: 44(0)7874047513.
Accepted Article
ACKNOWLEDGMENTS. The authors sincerely thank all the patients for their
participation in this study. The authors also appreciate the support received from the
following centres: Movement Disorders Clinic (Mexico), Ramon y Cajal University
Hospital (Spain), Vithas-Xanit International Hospital (Spain), JM Ramos Mejia Hospital
(Argentina), Neurological Service, Carlos Andrade Marin Hospital (Ecuador), and the
Department of Movement Disorders and Neurodegeneration, CIREN (Cuba).
FUNDING STATEMENT. No specific grant from any funding agency in the public,
commercial, or not-for-profit sectors has been received at this stage.
ABSTRACT
Aims and objectives: To identify the personal and disease related factors that are
associated to Living with Parkinson’s disease.
Background: Living with Parkinson’s disease affects the physical, psychological, social
and spiritual areas of the person. Health professionals need to know which factors
influence the daily Living with Parkinson’s disease, in order to facilitate a positive living.
Methods: 324 patients with a Parkinson’s disease diagnoses were included in the study
through a consecutive cases sampling. Data were collected from January to June 2015, in
specialized units of movement disorders of public and private and community centres,
Results: Results indicated that social support, followed by satisfaction with life and home
economical situation are the only three factors that significantly influence in Living with
Parkinson’s disease. The rest of the factors analysed did not present significant influence
in the daily Living with this neurodegenerative disease.
Conclusion: This study highlights the necessity to put more emphasis on the person and
his/her daily Living with the condition and less on symptoms and treatment. Health
professionals need to develop person centred interventions that also deal with other
elements of the experience of living with a long-term condition like Parkinson’s disease.
INTRODUCTION
Demographic changes happening in the 20th century in the Western world such as ageing
and the increase in life expectancy have produced a significant growth in long-term
conditions (LTCs) in the contemporary society. In particular, LTCs have become a leading
health related issue (WHO, 2017). Among LTCs, neurodegenerative and progressive
disorders like Parkinson’s disease (PD) stand out. PD is the second most common
neurodegenerative disease, after Alzheimer’ disease, affecting 1% of all people over 60
years of age in industrialized countries (de Lau and Breteler, 2006). PD prevalence is
increasing and it is expected that the number of people with PD will double by 2030
BACKGROUND
PD is a complex and disabling disorder manifested through a combination of specific
motor and non-motor symptoms that generate an important psychological and social
impact on the person who suffers the disease (Kalia and Lang, 2015, Lees et al. 2009,
Poewe et al. 2017). A recent study of PD patients showed a high proportion of patients
reporting non-motor symptoms such as hallucinations, depression or cognitive decline,
affecting negatively in their daily living with the disease (Findley, 2007). In this way,
throughout the PD course, patients do not only experience a progressive intensification of
PD specific symptoms but also have to cope and deal with an increasing limitation in all
areas of their daily Living with PD as a consequence of the disease (Haahr et al. 2011,
Hermanns, 2011).
Living with a LTC like PD has been recently defined as a complex, dynamic, cyclic and
multidimensional process that involves key elements, as acceptance, coping or adjustment
(REFERENCE BLINDED FOR PEER REVIEW). Living with PD affects the patients’
physical state together with other essential aspects in his/her life, such as the
psychological, social and spiritual ones (Kang and Ellis-Hill, 2015, Navarta-Sanchez et al.
2017).
In this context, healthcare professionals and especially nurses need to be aware and adopt
a comprehensive approach so that all aspects of the patients, understood as a bio-psycho-
social and spiritual being, are individually addressed (Fix et al. 2018, WHO, 2018).
Nurses play an essential role and need to reconsider daily practice to focus on the person
and not just on the disease, symptoms and treatment. Hence, identifying and
understanding which factors could affect the person’s living experience with PD is
necessary to provide care according to the patient individual and unique needs
(REFERENCE BLINDED FOR PEER REVIEW, Lees et al. 2009, REFERENCE
METHODS
Hypotheses
Based on previous research (Kang and Ellis-Hill, 2015, Zaragoza et al. 2014), we
hypothesized that highly perceived levels of social support of the patient are related to a
positive Living with PD (H1); more satisfaction with life is related to a positive living
with PD (H2); a better home economical situation is related to positive Living with PD
(H3); being at an initial or less severe stage of PD is related to a positive Living with the
condition (H4); and less burden of PD motor and non-motor symptoms is related to a more
positive Living with PD (H5).
Study design
This was an international study with an observational and cross-sectional design which
took place in five countries (Spain, Argentina, Ecuador, Mexico, Cuba). This research was
part of a multidisciplinary research programme called XXX (REFERENCE BLINDED
FOR PEER REVIEW), whose general purpose is to design individualized interventions to
normalise the experience of living with LTCs for patients and family/carers through the
development, implementation and evaluation of individualised multiagency interventions.
Assessments
Socio-demographic data (age, gender, marital status, employment situation and
educational level) and PD historic data (age at PD onset, PD duration and PD treatment
duration) were collected. In addition, nine measures were applied. All of them had been
validated to Spanish, presented adequate reliability and validity values, and were open
access or authors had the licence/permission to use them. The applied measures were the
following:
Rater-based assessments
The Hoehn and Yahr stage (HY) was used to evaluate the overall severity of the disease.
This scale classifies the severity of PD into five stages from 1 (without functional issue) to
5 (wheelchair bound or bedridden unless aided) (Hoehn and Yahr, 1967).
The Clinical Impression of Severity Index-PD (CISI-PD) was used to evaluate the global
impression of PD severity in four areas: motor signs, disability, motor complications and
cognitive status. Each item is rated on a range of 0 (normal, no affectation) to 6 (very
Patient-reported assessments
The SCOPA-PS was used to evaluate the psychosocial functioning of the patient during
the preceding month. It is a self-reported 11-item questionnaire where each item is scored
from 0 (not psychosocial problems at all) to 3 (maximum level of problems). The
summary index is obtained by summing up direct item scores transformed into percentage
values (Marinus et al. 2003, Martinez-Martin et al. 2009c).
The Duke-UNC Functional Social Support Questionnaire (DUFSS) was used to evaluate
the social support of the patients’ from his/her perspective. The DUFSS is a self-reported
measure that comprises 11 items that evaluate diverse dimensions of social support as
confidant, affective and instrumental support. The score for each item varies from 1 (much
less than I would like) to 5 (as much as I would like). Total score ranges from 11 (lowest
level of support ‘much less than I would like’) to 55 (highest level of support ‘as much as I
like’) (Ayala et al. 2012, Broadhead et al. 1988).
The Satisfaction with Life Scale (SLS) is a 7-item self-reported questionnaire. For this
study, a modified version of the SLS was used because the original version was specific
for a student population. In this way, a modified version with 6-item scale (SLS-6) was
used to evaluate the degree of overall satisfaction with life (item 1) and regarding five
Data collection
All measures were completed during the consultation with the neurologist, from January
to June 2015. The neurologist completed the rater-based assessments and in addition, the
participants filled in the patient-reported assessments. In order to ensure homogeneity in
all the participating countries and reduce possible errors during data collection, the
principal investigator of the project developed a data collection protocol with the
following steps: presentation of information about the research programme and in
particular this study; clarification of doubts; reading out load instructions measuring scales
completed with the neurologist and their items and answers, selecting the answer chosen
by the patient; reading out load instructions of the self-reported scales and giving
participants time to complete them. The average time to complete the self-reported scales
was 45 minutes.
Ethical considerations
The study was approved by the Institutional Review Board of the XXX and the other
participating countries (IRB No.: 071/2014). Patients gave their consent to participate
voluntarily after receiving the pertinent oral and written information. All data and
information about the participants’ identity were handled in full confidentiality throughout
the research process. No ethical conflicts emerged.
Rigour
To ensure the rigour of the study, we administered instruments validated in a Spanish
population with excellent psychometric properties. In particular, the EC-PC is a reliable
instrument with satisfactory Cronbach’s alpha (α ≥0.70) in patients living with PD.
Besides, validity showed satisfactory in convergent, internal and known-groups validity
coefficients (REFERENCE BLINDED FOR PEER REVIEW). In addition, Guba and
Lincoln (1981) criteria of trustworthiness were used to ensure rigour in quantitative
research. To ensure truth-value patient-reported assessments were included and a
standardized protocol was used in all participating centres. The data of this study emerged
form the validation study of the EC-PC (REFERENCE BLINDED FOR PEER REVIEW).
RESULTS
A total of 324 patients with PD were included. Socio-demographic and PD related
characteristics of the sample are shown in Table 1. Most of patients in the sample were
married, retired and had primary or secondary education level. Most of patients (85.8%)
were in intermediate HY stages (55.25% stage 2; 30.56% stage 3), although all stages
were represented. There were no missing data and the average scores of included measures
were, overall, at indicative levels of moderate to mild of their respective constructs. Part of
the descriptive statistics for PD related variables and assessments in the study, and for the
EC-PC were mentioned in a previous manuscript (REFERENCE BLINDED FOR PEER
REVIEW) (Tables 2 and 3).
According to the correlation coefficient values, DUFSS showed strong association (rS =
0.61) with EC-PC total score. A moderate correlation was identified between EC-PC and
SLS-6 (rS = 0.46). Moderate correlations (rs = 0.32-0.48) were also identified between EC-
PC domains and the other assessments: NMSS with domain 1-Acceptance; SCOPA-PS
with domain 1-Acceptance; DUFSS with domain 5-Adjustment; and SLS-6 with domain
1-Acceptance, 4-Integration, and 5-Adjustment. All these correlations were significant (p
< 0.001). Weak or negligible correlations were found between EC-PC and the clinician-
based PD assessments (Table 3).
DISCUSSION
Results in this study could establish some basic notions for a more comprehensive
approach of PD management, showing key factors that influence the experience of Living
with PD and including a specific measure in this regard (EC-PC). To our knowledge, this
is the first study that analyses and reports on the factors that influence in Living with a
LTC, in particular with PD.
One of the key results in this study showed a clear positive association between patients’
social support perception and Living with PD. Furthermore, our subsequent multiple linear
regression analysis confirmed this influence and we can state that social support is the
most influencing factor of Living with PD confirming hypothesis 1 of this study.
The identification of social support as a star factor when it comes to PD is not new in the
literature and from a qualitative and quantitative perspective this has been intuited before
(Dunk et al. 2017, Kang and Ellis-Hill, 2015) with a special focus on the support given by
nurses (Kang and Ellis-Hill, 2015, Wang et al. 2014). However, our results are novel as
this association has never been determined with Living with PD from a quantitative
perspective. Living with a LTC as a phenomenon bears complexity and should not be
simplified to processes like self-management or acceptance of the diagnosis, which are
inner parts of the former (REFERENCE BLINDED FOR PEER REVIEW). This is
illustrated in the other associations presented in table 4 as all domains but Acceptance
were clearly influenced by the perceived social support and non-motor symptoms
Limitations
Due to the cross-sectional design and the specific cultural context of the study population
the results must be interpreted with caution. However, an important strength is that
Spanish speaking-population is the second most spoken language in the world, after
Chinese, with 399 million of speakers (Ethnologue, 2015). Therefore, the inclusion of
patients from five different countries supports the consistency of the results at least for this
cultural and linguistic setting. Besides, the patients included in the study were also
CONCLUSIONS
The results in this study illustrate the need to place the emphasis on the person and in
his/her daily living with the disease, and not just on the disease. Each person with a LTC,
as PD, must be seen as a unique and unrepeatable person, independently of the stage or the
severity of the disease. Therefore, it is necessary to incorporate multidisciplinary and
individualized interventions in nowadays health services, focusing on the factors that
directly influence in Living with PD, as for social support, satisfaction and economic
status. Consequently, possible negative aspects of the daily Living with PD as lack of
support, loneliness or dissatisfaction with life could be prevented and a more positive
living achieved. So, this study advocates the necessity to put the comprehensive needs of
people and communities, at the centre of health systems, empowering people to have a
positive living and active role in their own health. Future research in other settings and
countries is needed to confirm the generalizability of these findings. Besides, person
centre interventions or individualized healthcare plans could be implemented in clinical
practice, incorporating non-pharmacological or PD specific measures that address the
factor(s) that are paramount in the daily Living with a LTC. In this regard, PD
programmes that mobilise and optimize the use of community resources, increase personal
networks and social support seem to be the direction for the management of
neurodegenerative conditions.
RELEVANCE TO PRACTICE
Elements related to the perceived social support of the person with Parkinson’s disease
and satisfaction with life play a key role in the living with a LTC like PD. Besides, Living
with PD is not influenced by disease related factors, namely duration, stage, or specific
motor symptoms. Consequently, research based interventions operationalised in clinical
practice require a change of direction to tackle and prevent loneliness and include
interagency elements. This could lead to finding community resources and systems of
support, which could sustain management programmes for neurodegenerative conditions
in nowadays healthcare systems.
Antonovsky, A. (1987). Unravelling the mystery of health: how people manage stress and
Accepted Article
stay well. San Francisco: Jossey Bass Publishers.
Ayala, A., Rodríguez-Blázquez, C., Frades-Payo, B., Forjaz, M.J., Martínez-Martín, P.,
Fernández-Mayoralas, G., … Rojo-Pérez, F. (2012). Propiedades psicométricas del
Cuestionario de Apoyo Social Funcional y de la Escala de Soledad en adultos mayores no
institucionalizados en España. Gaceta Sanitaria, 26(4), 317-324.
Broadhead, W.E., Gehlbach, S.H., de Gruy, F.V., Kaplan, B.H. (1988). The Duke-UNC
Functional Social Support Questionnaire, Measurement of social support in family
medicine patients. Medical Care, 26(7), 709-723.
Chaudhuri, K.R., Martinez-Martin, P., Brown, R.G., Sethi, K., Stocchi, F., Odin, P., …
Schapira, A.H. (2007). The metric properties of a novel non-motor symptoms scale for
Parkinson’s disease: results from an international pilot study. Movement Disorders,
22(13), 1901-1911.
de Lau, L.M., & Breteler, M.M. (2006). Epidemiology of Parkinson’s disease. The Lancet
Neurology, 5(6), 525-535.
Dorsey, E.R., Constantinescu, R., Thompson, J.P., Biglan, K.M., Holloway, R.G.,
Kieburtz, K., … Tanner, C.M. (2007). Projected number of people with Parkinson disease
in the most populous nations, 2005 through 2030. Neurology, 68(5), 384-386.
Dunk, M., Engblom, H., Gissen, M., Joseph, E., Po-Fai Li, J., Russell, D.W., … McRae,
C. (2017). Social Support and Loneliness Among Parkinson Care Partners. Medical
Research Archives, 5(8), 1-14.
Ethnologue (2015). Languages of the world. Summary by the language size. Available in:
http://www.ethnologue.com/statistics/size.
Findley, L.J. (2007). The economic impact of Parkinson’s disease. Parkinsonism &
Related Disorders, 13, S8-S12.
Fix, G.M., Lukas, C.V., Bolton, R.E., Hill, J.N., Mueller, N., LaVela, S.L., & Bokhour,
B.G., (2018). Patient-centred care is a way of doing things: how healthcare employees
conceptualize patient-centred care. Health Expectations, 21(1), 300-307.
Gustafsson, H., Nordström, A., Strahle, S., & Nordström, P. (2015). Parkinson’s Disease:
A population-based investigation of life satisfaction and employment. Journal of
Rehabilitation Medicine, 47(1), 45-51.
What does this paper contribute to the wider global clinical community?
Accepted Article
Interventions to foster positive living with Parkinson’s disease should integrate
strategies to tackle and prevent loneliness and interagency elements to increase
community resources and systems of support
Parkinson’s disease programmes that mobilise and optimize the use of community
resources, increase personal networks and social support seem to be the direction for
the management of neurodegenerative conditions
EC-PC domains
EC-PC
Total score Domain 1- Domain 2- Domain 3- Self- Domain 4- Domain 5-
Acceptance Coping Management Integration Adjustment
Hoehn & Yahr -0.09 -0.17 -0.05 -0.02 -0.13 -0.02
CISI-PD -0.16 -0.25 -0.07 -0.03 -0.14 -0.15
SCOPA-M -0.08 -0.27 -0.01 0.07 -0.03 -0.14
NMSS -0.32 -0.36 -0.23 -0.18 -0.24 -0.19
SCOPA-PS -0.25 -0.40 -0.09 -0.08 -0.23 -0.24
DUFSS 0.61 0.12 0.61 0.57 0.57 0.36
SLS-6 0.46 0.43 0.29 0.28 0.33 0.48
CISI-PD: Clinical Impression of Severity Index-PD. SCOPA-M: The Scales for Outcomes in Parkinson’s Disease-Motor. NMSS: Non-Motor
Symptoms Scale. SCOPA-PS: Scales for Outcomes in Parkinson’s Disease-Psychosocial. DUFSS: Duke-UNC Functional Social Support
Questionnaire. SLS-6: Satisfaction with Life Scale- 6 items. EC-PC: Living with Chronic illness-PD Scale.
-0.11 *
Age
(-0.12 – -0.00)
-0.16 **
Gender
(-2.46 – -0.56)
0.15 *
Duration of PD
(0.03 – 0.22)
0.26 *** 0.29 *** 0.12 * 0.34 ***
SLS-6
(1.56 – 3.35) (-0.52 – 0.05) (0.03 – 0.44) (0.67 – 1.40)
-0.10 * -0.19 ** -0.11 *
NMSS
(-0.08 – -0.002) (-0.03 – -0.01) (-0.02 – 0.00)
0.51 *** 0.58 *** 0.52 *** 0.55 *** 0.21 ***
DUFSS
(0.79 – 1.10) (0.33 – 0.48) (0.16 – 0.23) (0.21 – 0.30) (0.07 – 0.19)
-0.16 *** -0.19 *** -0.16 **
SEH
(-2.59 – -0.75) (-1.09 – -0.38) (-0.54 – -0.11)